ClinicalTrials.Veeva

Menu

Improved Screening for Osteoporosis (ADOV)

C

Centre Hospitalier Departemental Vendee

Status

Completed

Conditions

Osteoporosis

Study type

Observational

Funder types

Other

Identifiers

NCT02066480
CHD 086-13

Details and patient eligibility

About

Osteoporosis is a disease characterized by skeletal fragility due to decreased bone mass and deterioration of bone microarchitecture , leading to increased fracture risk for low trauma, such as spinal fractures or femoral neck .

It is estimated that 3 million people are living in France , particularly women , with an incidence that increases with age .

This disease is a major public health issue in terms of morbidity and mortality , costs and risk of recurrence (after a first fracture episode) , including risk factors are identified.

However, although bone densitometry is a reliable diagnostic tool and preventive treatments are at our disposal, screening for osteoporosis is still insufficient .

The objective of our study is to improve the detection of osteoporosis in Hospital Departmental Vendee , using a simple questionnaire seeking risk factors followed by bone densitometry or if risk factors are found. Based on the results , the patient will be sent in rheumatology consultation for implementation of treatment if necessary .

Therefore included women hospitalized in medical services , gynecology, surgery and orthopedics Hospital Departmental Vendee , aged 50 to 80 years. Will not be included women who could answer a simple questionnaire and those previously treated for osteoporosis or have already received a bone density there is less than 3 years old .

Enrollment

3,226 patients

Sex

Female

Ages

50 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Women between 50 and 80 years
  • Hospitalized
  • In health services, orthopedics, gynecology, surgery
  • Able to respond to an easy questionnaire
  • Able to give their agreement to participate in the study

Exclusion criteria

  • Patients with dementia
  • Patients can not express
  • Patients at end of life
  • Patients previously treated for osteoporosis or recent densitometry (BMD) <3 years
  • Patients could not be seen in time by the nurse during their hospitalization
  • Patients receiving a measure of legal protection

Trial design

3,226 participants in 1 patient group

women between 50 and 80 years hospitalized in CHD Vendée

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems